Corticosteroid transdermal delivery to target swelling, edema and inflammation following facial rejuvenation procedures

References

• Buys LM Treatment options for atopic dermatitis Am Fam Physician 2007 75 4 523 528 17323714
   PubMed Web of Science ®Google Scholar
• Lipozencić J Wolf R Atopic dermatitis: an update and review of the literature Dermatol Clin 2007 25 4 605 612 17903619
   PubMed Web of Science ®Google Scholar
• Menter A Griffiths CE Current and future management of psoriasis Lancet 2007 370 9583 272 284 17658398
   PubMed Web of Science ®Google Scholar
• Franz TJ Parsell DA Halualani RM Hannigan JF Kalbach JP Harkonen WS Betamethasone valerate foam 0.12%: a novel vehicle with enhanced delivery and efficacy Int J Dermatol 1999 38 8 628 632 10487457
   PubMed Web of Science ®Google Scholar
• Harris JJ A national double-blind clinical trial of a new corticosteroid lotion: a 12-investigator cooperative analysis Curr Ther Res Clin Exp 1972 14 9 638 646 4263888
   PubMed Web of Science ®Google Scholar
• Marks R Bhogal B Wilson L The effect of betamethasone valerate on seborrhoeic dermatitis of the scalp. A clinical, histopathological cell kinetic study Acta Derm Venereol 1974 54 5 373 375 4138231
   PubMed Web of Science ®Google Scholar
• Medansky RS Handler RM Treating psoriasis of the scalp with a new corticosteroid lotion IMJ Ill Med J 1974 145 6 503 504 4152499
   PubMedGoogle Scholar
• Milani M Di Molfetta AS Gramazio R Efficacy of betamethasone valerate 0.1% thermophobic foam in seborrhoeic dermatitis of the scalp: an open-label, multicentre, prospective trial on 180 patients Curr Med Res Opin 2003 19 4 342 345 12841928
   PubMed Web of Science ®Google Scholar
• Stein LF Sherr A Solodkina G Gotlieb AB Chaudhari U Betamethasone valerate foam for treatment of nonscalp psoriasis J Cutan Med Surg 2001 5 4 303 307 11907840
   PubMed Web of Science ®Google Scholar
• Mancuso G Balducci A Casadio C Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial Int J Dermatol 2003 42 7 572 575 12839615
   PubMed Web of Science ®Google Scholar
• Weiss SC Nguyen J Chon S Kimball AB A randomized controlled clinical trial assessing the effect of betamethasone valerate 0.12% foam on the short-term treatment of stasis dermatitis J Drugs Dermatol 2005 4 3 339 345 15898290
   PubMedGoogle Scholar
• Subedi RK Oh SY Chun MK Choi HK Recent advances in transdermal drug delivery Arch Pharm Res 2010 33 3 339 351 20361297
   PubMed Web of Science ®Google Scholar
• Pacifico A Daidone R Peris K A new formulation of an occlusive dressing containing betamethasone valerate 0.1% in the treatment of mild to moderate psoriasis J Eur Acad Dermatol Venereol 2006 20 2 153 157 16441622
   PubMed Web of Science ®Google Scholar
• Naldi L Yawalkar N Kaszuba A Efficacy and safety of the Betamethasone valerate 0.1% plaster in mild-to-moderate chronic plaque psoriasis: a randomized, parallel-group, active-controlled, phase III study Am J Clin Dermatol 2011 12 3 191 201 21284407
   PubMed Web of Science ®Google Scholar
• Salini V Abate M Percutaneous steroidal treatment in relapses of chronic tendinopathies: a pilot study Int J Immunopathol Pharmacol 2011 24 1 211 216 21496380
   PubMed Web of Science ®Google Scholar
• Saraceno R Chiricozzi A Nisticò SP Tiberti S Chimenti S An occlusive dressing containing betamethasone valerate 0.1% for the treatment of prurigo nodularis J Dermatolog Treat 2010 21 6 363 366 20536273
   PubMed Web of Science ®Google Scholar
• Iannitti T Capone S Palmieri B Short review on face rejuvenation procedures: focus on preoperative antiseptic and anesthetic delivery by JetPeel™-3 (a high pressure oxygen delivery device) Minerva Chir 2011 66 3 Suppl 1 1 8 21971508
   PubMedGoogle Scholar
• Palmieri B Capone S Mesoterapia con acido ialuronico. Trattamento di rughe e cicatrici per il ringiovanimento cutaneo [Mesotherapy with hyaluronic acid. Treatment of wrinkles and scars for skin rejuvenation] Hi Tech Dermo 2010 2 29 36 Italian
   Google Scholar
• Marusza W Mlynarczyk G Olszanski R Probable biofilm formation in the cheek as a complication of soft tissue filler resulting from improper endodontic treatment of tooth 16 Int J Nanomedicine 2012 7 1441 1447 22619504
   PubMed Web of Science ®Google Scholar
• Iannitti T Bingöl AO Rottigni V Palmieri B A new highly viscoelastic hyaluronic acid gel: rheological properties, biocompatibility and clinical investigation in esthetic and restorative surgery Int J Pharm Epub July 5 2013
   Google Scholar
• Iannitti T Rottigni V Torricelli F Palmieri B Combination Therapy of Hyaluronic Acid Mesotherapic Injections and Sclerotherapy for Treatment of Lower Leg Telangiectasia Without Major Venous Insufficiency: A Preliminary Clinical Study Clin Appl Thromb Hemost Epub 1 2 2013
   Web of Science ®Google Scholar
• Littara A Palmieri B Rottigni V Iannitti T A clinical study to assess the effectiveness of a hyaluronic acid-based procedure for treatment of premature ejaculation Int J Impot Res 2013 25 3 117 120 23552577
   PubMed Web of Science ®Google Scholar
• Palmieri B Rottigni V Iannitti T Preliminary study of highly cross-linked hyaluronic acid-based combination therapy for management of knee osteoarthritis-related pain Drug Des Devel Ther 2013 7 7 12
   PubMed Web of Science ®Google Scholar
• Iannitti T Rottigni V Palmieri B A pilot study to compare two different hyaluronic acid compounds for treatment of knee osteoarthritis Int J Immunopathol Pharmacol 2012 25 4 1093 1098 23298499
   PubMed Web of Science ®Google Scholar
• Iannitti T Lodi D Palmieri B Intra-articular injections for the treatment of osteoarthritis: focus on the clinical use of hyaluronic acid Drugs R D 2011 11 1 13 27 21142290
   PubMedGoogle Scholar
• Sirtori CR Aescin: pharmacology, pharmacokinetics and therapeutic profile Pharmacol Res 2001 44 3 183 193 11529685
   PubMed Web of Science ®Google Scholar
• Prausnitz MR Mitragotri S Langer R Current status and future potential of transdermal drug delivery Nat Rev Drug Discov 2004 3 2 115 124 15040576
   PubMed Web of Science ®Google Scholar
• Bircher AJ Howald H Rufli T Adverse skin reactions to nicotine in a transdermal therapeutic system Contact Dermatitis 1991 25 4 230 236 1839264
   PubMed Web of Science ®Google Scholar
• Buckley DA Wilkinson SM Higgins EM Contact allergy to a testosterone patch Contact Dermatitis 1998 39 2 91 92 9746197
   PubMed Web of Science ®Google Scholar
• Carmichael AJ Foulds IS Allergic contact dermatitis from oestradiol in oestrogen patches Contact Dermatitis 1992 26 3 194 195 1387059
   PubMed Web of Science ®Google Scholar
• Eichelberg D Stolze P Block M Buchkremer G Contact allergies induced by TTS-treatment Methods Find Exp Clin Pharmacol 1989 11 3 223 225 2725120
   PubMedGoogle Scholar
• Färm G Contact allergy to nicotine from a nicotine patch Contact Dermatitis 1993 29 4 214 215 8281791
   PubMed Web of Science ®Google Scholar
• Fisher AA Dermatitis due to transdermal therapeutic systems Cutis 1984 34 6 526 527 530–531 6240373
   PubMed Web of Science ®Google Scholar
• Gordon CR Shupak A Doweck I Spitzer O Allergic contact dermatitis caused by transdermal hyoscine BMJ 1989 298 6682 1220 1221 2526675
   PubMed Web of Science ®Google Scholar
• Jordan WP Clinical evaluation of the contact sensitization potential of a transdermal nicotine system (Nicoderm) J Fam Pract 1992 34 6 709 712 1593244
   PubMed Web of Science ®Google Scholar
• Machet L Martin L Toledano C Jan V Lorette G Vaillant L Allergic contact dermatitis from nitroglycerin contained in 2 transdermal systems Dermatology 1999 198 1 106 107 10026420
   PubMed Web of Science ®Google Scholar
• Pérez-Calderón R Gonzalo-Garijo MA Rodriguez-Nevado I Generalized allergic contact dermatitis from nitroglycerin in a transdermal therapeutic system Contact Dermatitis 2002 46 5 303 12084088
   PubMed Web of Science ®Google Scholar
• Rosenfeld AS White WB Allergic contact dermatitis secondary to transdermal nitroglycerin Am Heart J 1984 108 4 Pt 1 1061 1062 6237565
   PubMed Web of Science ®Google Scholar
• Shouls J Shum KW Gadour M Gawkrodger DJ Contact allergy to testosterone in an androgen patch: control of symptoms by pre-application of topical corticosteroid Contact Dermatitis 2001 45 2 124 125 11553134
   PubMed Web of Science ®Google Scholar
• Topaz O Abraham D Severe allergic contact dermatitis secondary to nitroglycerin in a transdermal therapeutic system Ann Allergy 1987 59 5 365 366 3120627
   PubMedGoogle Scholar
• Torres V Lopes JC Leite L Allergic contact dermatitis from nitroglycerin and estradiol transdermal therapeutic systems Contact Dermatitis 1992 26 1 53 54 1534736
   PubMed Web of Science ®Google Scholar
• Trozak DJ Delayed hypersensitivity to scopolamine delivered by a transdermal device J Am Acad Dermatol 1985 13 2 Pt 1 247 251 2931457
   PubMed Web of Science ®Google Scholar
• van der Willigen AH Oranje AP Stolz E van Joost T Delayed hypersensitivity to scopolamine in transdermal therapeutic systems J Am Acad Dermatol 1988 18 1 Pt 1 146 147 3346401
   PubMed Web of Science ®Google Scholar
• Vincenzi C Tosti A Cirone M Guarrera M Cusano F Allergic contact dermatitis from transdermal nicotine systems Contact Dermatitis 1993 29 2 104 105 8365171
   PubMed Web of Science ®Google Scholar